Music therapy shows promise in fighting chemo fatigue for leukemia patients
NCT ID NCT06286332
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether music therapy can help reduce fatigue and improve certain blood test results in people with acute myeloid leukemia who are going through chemotherapy for the first time. Sixty adults took part, and researchers measured their fatigue levels and lab values like white blood cell counts. The goal was to see if listening to music could be a simple, drug-free way to feel better during treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
60 people
The number who actually took part.
- Started
-
Apr 2024
- Finished
-
Jan 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Diagnosed with acute myeloid leukemia by a clinical specialist. 2. Patients undergoing chemotherapy for the first time. 3. Aged 18 years or older, capable of communicating in Mandarin or Taiwanese. 4. Normal hearing ability. 5. No history of psychiatric disorders and clear consciousness. 6. Participants with no prior involvement in any intervention studies related to fatigue management. 7. Demonstrates understanding of the research objectives, willingly participates in the study, and completes the informed consent form. 8. Willing to cooperate with study procedures throughout the research period. Exclusion Criteria: 1. Severe hearing impairment. 2. Individuals with unstable vital signs or altered consciousness.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute myeloid leukemia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chang Gung Memorial Hospital, Linkou
Taoyuan, Taiwan, 333, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can exercising with your baby reshape postpartum recovery?
- Can a p53-Targeting drug boost chemotherapy in Hard-to-Treat blood cancers?
- Can an HDAC inhibitor wipe out residual leukemia cells?
- Can an experimental pill block a cancer-driving enzyme in hard-to-treat leukemia?
- Two-Drug combo targets leukemia that outsmarted its first treatment
- Tweaking donor cells may shield older transplant patients from a dangerous complication